Published in Gene Therapy Weekly, April 10th, 2008
This is the report for professionals interested to grasp the field of apoptopic drug targets in oncology and at the same time have an extensive R&D overview of lung cancer and melanoma. This extensive 540+ pages report compiles and analyzes Apoptosis, the type of death about whose genetically controlled pathways we know the most, and further give an in depth analysis in two key oncology areas; Breast- and Prostate cancer
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.